AtriCure News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.01.24	Key Takeaways From AtriCure Analyst Ratings (Benzinga)
20.12.23	AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Businesswire)
29.11.23	Where AtriCure Stands With Analysts (Benzinga)
15.11.23	AtriCure to Participate in the Piper Sandler 35th Annual Healthcare Conference (Businesswire)
14.11.23	AtriCure Releases 2023 ESG Report (Businesswire)
01.11.23	AtriCure Reports Third Quarter 2023 Financial Results (Businesswire)
31.10.23	AtriCure to Participate in the Stifel 2023 Healthcare Conference (Businesswire)
31.10.23	Ausblick: AtriCure legt Zahlen zum jüngsten Quartal vor (finanzen.net)
25.07.23	AtriCure Reports Second Quarter 2023 Financial Results (Businesswire)
24.07.23	Ausblick: AtriCure veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
21.07.23	AtriCure to Participate at Upcoming Investor Conferences (Businesswire)
10.07.23	Erste Schätzungen: AtriCure zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
03.07.23	AtriCure to Announce Second Quarter 2023 Financial Results (Businesswire)
02.05.23	AtriCure Reports First Quarter 2023 Financial Results (Businesswire)
01.05.23	Ausblick: AtriCure gewährt Anlegern Blick in die Bücher (finanzen.net)
19.04.23	AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast (Businesswire)
17.04.23	Erste Schätzungen: AtriCure stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net)
11.04.23	AtriCure to Announce First Quarter 2023 Financial Results (Businesswire)
03.04.23	AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference (Businesswire)
21.02.23	AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results (Businesswire)
20.02.23	Ausblick: AtriCure verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
17.02.23	AtriCure to Participate in the Oppenheimer 33rd Annual Healthcare Conference (Businesswire)
06.02.23	Erste Schätzungen: AtriCure präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
31.01.23	AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial (Businesswire)
24.01.23	AtriCure to Announce Fourth Quarter and Full Year 2022 Financial Results and Participate in 2023 BTIG Medical Technology Conference (Businesswire)
09.01.23	AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2022, Provides Financial Outlook for 2023 (Businesswire)
20.12.22	AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference (Businesswire)
08.12.22	AtriCure Wins 2022 NACD Diversity, Equity, & Inclusion Award (Businesswire)
08.11.22	AtriCure to Present at 34th Annual Piper Sandler Healthcare Conference (Businesswire)
01.11.22	AtriCure Reports Third Quarter 2022 Financial Results (Businesswire)
25.10.22	AtriCure to Participate in Upcoming Investor Conferences (Businesswire)
17.10.22	Erste Schätzungen: AtriCure legt Quartalsergebnis vor (finanzen.net)
11.10.22	AtriCure to Announce Third Quarter 2022 Financial Results (Businesswire)
06.09.22	AtriCure Announces Investor Education Webcast with Hybrid AF Therapy Key Opinion Leaders (Businesswire)
16.08.22	AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (Businesswire)
03.08.22	ATRC Sees 18-21% Revenue Growth, EVH Q2 Results Beat Estimates, EXAS Trims Outlook, HRMY On Watch... (RTTNews)
02.08.22	AtriCure Reports Second Quarter 2022 Financial Results (Businesswire)
01.08.22	Ausblick: AtriCure stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
20.07.22	AtriCure to Participate at Upcoming Investor Conferences (Businesswire)
18.07.22	Erste Schätzungen: AtriCure präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
12.07.22	AtriCure to Announce Second Quarter 2022 Financial Results (Businesswire)
07.06.22	AtriCure teilt mit, dass der erste Patient im Rahmen der klinischen Studie HEAL-IST behandelt wurde (Businesswire)
07.06.22	AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial (Businesswire)
01.06.22	AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer (Businesswire)
26.05.22	AtriCure - For A Healthy Heart (RTTNews)
04.05.22	ATRC Sees 16-20% Revenue Growth, RIGL On Watch, LUNG Breathes Easy, BPMC Braces For Busy Year (RTTNews)
03.05.22	AtriCure Reports First Quarter 2022 Financial Results (Businesswire)
03.05.22	Ausblick: AtriCure gewährt Anlegern Blick in die Bücher (finanzen.net)
18.04.22	Erste Schätzungen: AtriCure stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net)
12.04.22	AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	122.00	2.91 %	K V
Lonza Grp	528.00	1.27 %	K V
Swiss Re	129.90	1.25 %	K V
Logitech Intl	71.88	1.21 %	K V
UBS Group	28.37	0.25 %	K V
ABB	49.83	-0.66 %	K V
Swiss Life Hldg	727.40	-0.85 %	K V
Givaudan	3’895.00	-0.97 %	K V
Novartis	92.29	-1.48 %	K V
Sonova Hldg	306.40	-1.83 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu AtriCure Inc

Aktien Top/Flop

Meistgelesene Nachrichten